Carson Allaria Wealth Management, Ltd. Charles River Laboratories International, Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $167 Million
- Q1 2025
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 71 shares of CRL stock, worth $10,721. This represents 0.01% of its overall portfolio holdings.
Number of Shares
71
Previous 71
-0.0%
Holding current value
$10,721
Previous $13,000
23.08%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$922 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$768 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$647 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$361 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$294 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.68B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...